1v1 Institutional Counterparty Comparison
Clone Finance vs Surgirux: Regulation, 6D Ratings & Safety Audit
Deterministic head-to-head benchmarking of Clone Finance (Clone Finance Advisory AG) and Surgirux (Surgirux) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.
Coverage: Crypto exchanges and digital-asset service providers
- Clone Finance 6D Score
- 1.0
- Surgirux 6D Score
- 2.0
- Regulated Licences
- 0 vs 0
- Warning Flags
- 0 vs 0
Surgirux outranks Clone Finance by +1.0 pts in composite 6D scoring (2.0 vs 1.0)
On supervisory breadth, Clone Finance holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s), whereas Surgirux holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning flag(s). Allocators should verify the exact licence numbers, domains, and contracting legal entities below before onboarding.
Direct Verification & Supervisory Regulator Dossiers
Cross-check each counterparty's licence status, registered domains, and issuing regulator frameworks.
Clone Finance
0 Regulated · 0 Tier-1Legal reference: Clone Finance Advisory AG
Issuing Regulator Dossiers
No linked regulator dossier in current directory. Browse all regulators →
Surgirux
0 Regulated · 0 Tier-1Legal reference: Surgirux
Issuing Regulator Dossiers
No linked regulator dossier in current directory. Browse all regulators →
6-Dimension Quantitative Scorecard Comparison
Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).
6D Compliance Score Visual Profile (0.0 – 10.0)
| Evaluation Dimension | Methodology Weight | Clone Finance | Surgirux | Score Delta | Dimension Leader |
|---|---|---|---|---|---|
| Overall Composite 6D Score | 100% Composite | 1.0 | 2.0 | +1.0 | Surgirux |
| Regulatory & Licensing Integrity | 30% Weight | 1.0 | 2.0 | +1.0 | Surgirux |
| Execution & Software Infrastructure | 20% Weight | 1.0 | 1.0 | 0.0 | Statistical Tie |
| User Reputation & Complaint Telemetry | 20% Weight | 0.0 | 0.0 | 0.0 | Statistical Tie |
| Institutional Brand Longevity | 15% Weight | 1.0 | 2.0 | +1.0 | Surgirux |
| Global Market Influence & Footprint | 15% Weight | 1.0 | 2.0 | +1.0 | Surgirux |
Visual 6D Compliance Benchmark: Clone Finance vs Surgirux
Vector comparison exhibit contrasting 6-dimension compliance pillars, Tier-1 regulatory authorisations, and exposure telemetry.
Regulatory Standing, Entity & Platform Comparison
Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.
| Audit Attribute | Clone Finance | Surgirux |
|---|---|---|
| Primary Legal Name | Clone Finance Advisory AG | Surgirux |
| Regulatory Risk Standing | Pending Review | Pending Review |
| Active Regulated / Total Filings | 0 regulated / 0 total (0 Tier-1) | 0 regulated / 0 total (0 Tier-1) |
| Supervisory Regulators & Certificates | None on file | None on file |
| Registered Domicile / Address | CH | Könizstrasse 161, 3097 Liebefeld, Switzerland |
| Offered Asset Classes & Services | Cryptocurrencies, Indices, Forex, Stocks | Cryptocurrencies, Indices, Forex, Stocks |
| Execution Software & Terminals | Proprietary / Web Platform | Proprietary / Web Platform |
| Supported Client Languages | English | English, French, German |
| Warning / Exposure Count | 0 recorded warning(s) | 0 recorded warning(s) |
| Direct Licence & Domain Check | Verify Clone Finance → | Verify Surgirux → |
Related Head-to-Head Peer Comparisons
Explore additional institutional matchups involving peers of Clone Finance and Surgirux.
Blackwell Global vs Clone Finance
Compare side-by-side →Binance DEX vs Clone Finance
Compare side-by-side →bybit vs Clone Finance
Compare side-by-side →Clone Finance vs FxPro
Compare side-by-side →Blackwell Global vs Surgirux
Compare side-by-side →Binance DEX vs Surgirux
Compare side-by-side →Frequently Asked Questions: Clone Finance vs Surgirux
Deterministic counterparty comparison answers derived from supervisory records.
Which institution has stronger regulatory oversight: Clone Finance or Surgirux?
Both Clone Finance and Surgirux hold 0 active regulated licence record(s) in our registry. Specifically, Clone Finance maintains 0 recorded filing(s) (none on file) with 0 warning flag(s), whereas Surgirux maintains 0 recorded filing(s) (none on file) with 0 warning flag(s). Always confirm the exact contracting legal subsidiary on the issuing regulator's public register before funding an account.
How do the 6D quantitative compliance scores compare between Clone Finance and Surgirux?
In Institutional Ledger's 6-Dimension scoring matrix (0.0–10.0 scale), Clone Finance records an Overall Score of 1.0 (Risk & Licensing: 1.0, Execution & Software: 1.0, User Reputation: 0.0, Brand Longevity: 1.0, Market Influence: 1.0), compared with Surgirux at 2.0 Overall (Risk & Licensing: 2.0, Execution & Software: 1.0, User Reputation: 0.0, Brand Longevity: 2.0, Market Influence: 2.0).
How do Clone Finance and Surgirux differ in trading platforms and asset classes?
Clone Finance lists Cryptocurrencies, Indices, Forex, Stocks with execution software [proprietary/web execution], while Surgirux lists Cryptocurrencies, Indices, Forex, Stocks with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per contracting entity.
How can I verify the licences and official domains of Clone Finance and Surgirux?
Use our dedicated verification lookup pages for Clone Finance (/verify/clone-finance) and Surgirux (/verify/surgirux) to cross-check recorded licence numbers and registered domains, then confirm the exact entity name, permissions, and approved website URL directly on the issuing regulator's official register. Clone Finance currently carries "Pending Review" standing (0 exposure flag(s)) versus "Pending Review" (0 exposure flag(s)) for Surgirux.
Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.
